Portable Ultrasound Monitoring for Premature Infant Monitoring
(POCUS Trial)
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Portable Ultrasound Monitoring for Premature Infant Monitoring is an effective treatment?
The available research shows that Portable Ultrasound Monitoring, also known as Point of Care Ultrasound (POCUS), is a valuable tool in pediatric and neonatal care. It is particularly useful in emergency and critical care settings for diagnosing and managing various conditions in children, including respiratory issues and injuries. The studies highlight its effectiveness due to its ease of use, ability to provide immediate results, and non-invasive nature. While the research does not specifically address its use for premature infant monitoring, the general benefits of POCUS in pediatric care suggest it could be an effective treatment option.12345
What safety data exists for portable ultrasound monitoring in premature infants?
The available research suggests that point-of-care ultrasound (POCUS) is considered a safe and non-invasive tool widely used in emergency, intensive care, and neonatal settings. It is increasingly popular among non-radiologist clinicians for its accessibility and utility in managing unwell patients, including in neonatal intensive care units (NICUs). However, specific safety data for its use in premature infant monitoring is not detailed in the provided research.16789
Is portable ultrasound a promising treatment for monitoring premature infants?
Yes, portable ultrasound is a promising treatment for monitoring premature infants. It offers greater portability and affordability, making it easier to use in various settings. This technology allows for quick and effective monitoring, similar to how a stethoscope is used, but with visual images. It is expected to become a common tool for doctors, providing valuable information for patient care.1011121314
What is the purpose of this trial?
The research will find out if using portable ultrasound devices by nurses can make it quicker to get babies from 24 to 32 weeks on the doppler monitor.
Eligibility Criteria
This trial is for pregnant women aged 18 to 50 with a single baby between 24 and 32 weeks of gestation. It's not suitable for those outside this pregnancy window, under age 18, if the fetus has a known lethal anomaly where monitoring was declined, or if they are incarcerated.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Nurses use handheld ultrasound devices to assist with applying continuous external fetal monitoring (cEFM) in early preterm pregnancies
Follow-up
Participants are monitored for the time to successful detection of fetal heart rate and any need for physician intervention
Treatment Details
Interventions
- Continuous Fetal Monitoring
- Point of Care Handheld Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor